Burak Kocak
Research Subjects
Burak Kocak has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Başak Akyollu
Prof. Munci Kalayoglu, M.D. Organ Transplant Center, Koc University Hospital, Istanbul, Türkiye
5 shared publications - Emre Arpali
Division of Transplant Surgery, Medical College of Wisconsin, Milwaukee, USA
4 shared publications Alan J. Koffron
Division of Organ Transplantation, Department of Surgery, Northwestern University Medical School, Chicago, Illinois
3 shared publications- Cihan Karataş
Koc Univ Hosp, Dept Liver Transplantat, Istanbul, Turkiye
3 shared publications - Ilmay Bilge
Pediatric Nephrology Department Koç University Faculty of Medicine Istanbul Turkey
3 shared publications Joseph R. Leventhal
Division of Organ Transplantation, Department of Surgery, Northwestern University Medical School, Chicago, Illinois
3 shared publications
Latest Publications
- 9 November 2026
- Published by Springer Nature in Pediatric Nephrology
- p. 1-17
Pediatric living-donor kidney transplantation in infants and low-weight children: what have we learned so far?
- 9 November 2026
- Published by Springer Nature in Pediatric Nephrology
- p. 1-17
Pediatric living-donor kidney transplantation in infants and low-weight children: what have we learned so far?
- 27 May 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (11) , 2548-2556
Long-term renal outcomes in living kidney donors with asymptomatic nephrolithiasis: A 10-year single-center study
- 27 May 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (11) , 2548-2556
Long-term renal outcomes in living kidney donors with asymptomatic nephrolithiasis: A 10-year single-center study
- 30 November 2025
- Published by Wiley in Pediatric Transplantation
- Vol. 29 (8) , e70234
Successful Use of Haploidentical HSCT in a Child With Schimke Immuno‐Osseous Dysplasia Who Developed PTLD After Kidney Transplantation
Background: Schimke Immuno‐Osseous Dysplasia Is a Rare Autosomal Recessive Multisystem Disorder Caused by Biallelic Pathogenic Variants in the SMARCAL1 Gene, Which Encodes a DNA Annealing Helicase Essential for Replication Fork Stability and Genomic Maintenance. Loss of SMARCAL1 Function Leads to Genomic Instability, Resulting in a Characteristic Clinical Triad of Disproportionate Short Stature, Steroid‐Resistant Nephrotic Syndrome and Immunodeficiency. Kidney Transplantation Is the Standard Treatment for End‐Stage Renal Disease in Schimke Immuno‐Osseous Dysplasia. However, the Underlying Genomic Fragility and Immunodeficiency Heighten the Risk of Post‐Transplant Complications, Particularly Epstein–Barr Virus‐Associated Post‐Transplant Lymphoproliferative Disorder. Method: We Report the Case of a 7‐Year‐Old Girl With Genetically Confirmed Schimke Immuno‐Osseous Dysplasia Who Developed Epstein–Barr Virus‐Positive Diffuse Large B‐Cell Lymphoma Eight Months Following Maternal Kidney Transplantation, Despite Reduced‐Intensity Immunosuppression. Rituximab Therapy Resulted in Complete Remission, but Required the Withdrawal of all Immunosuppressive Agents, Thereby Posing a Risk of Kidney Graft Loss. Result: In the Context of Primary Immunodeficiency and the Development of Post‐Transplant Lymphoproliferative Disorder in Such a Setting, the Patient Subsequently Underwent Haploidentical Hematopoietic Stem Cell Transplantation From the Mother, Using an αβ T‐Cell‐Depleted Graft and a Nephrotoxicity‐Sparing Conditioning Regimen. Full Donor Chimerism Was Achieved by Day 28. Immune Reconstitution Occurred Within One Year. At 27 Months After Hematopoietic Stem Cell Transplantation She Remains in Remission With Preserved Kidney Function and no Ongoing Immunosuppression. Conclusion: This Case Highlights the Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation as a Curative Salvage Strategy for Immunosuppression‐Free Survival After Kidney Transplantation in Patients With Schimke Immuno‐Osseous Dysplasia.
- 30 November 2025
- Published by Wiley in Pediatric Transplantation
- Vol. 29 (8) , e70234
Successful Use of Haploidentical HSCT in a Child With Schimke Immuno‐Osseous Dysplasia Who Developed PTLD After Kidney Transplantation
Background: Schimke Immuno‐Osseous Dysplasia Is a Rare Autosomal Recessive Multisystem Disorder Caused by Biallelic Pathogenic Variants in the SMARCAL1 Gene, Which Encodes a DNA Annealing Helicase Essential for Replication Fork Stability and Genomic Maintenance. Loss of SMARCAL1 Function Leads to Genomic Instability, Resulting in a Characteristic Clinical Triad of Disproportionate Short Stature, Steroid‐Resistant Nephrotic Syndrome and Immunodeficiency. Kidney Transplantation Is the Standard Treatment for End‐Stage Renal Disease in Schimke Immuno‐Osseous Dysplasia. However, the Underlying Genomic Fragility and Immunodeficiency Heighten the Risk of Post‐Transplant Complications, Particularly Epstein–Barr Virus‐Associated Post‐Transplant Lymphoproliferative Disorder. Method: We Report the Case of a 7‐Year‐Old Girl With Genetically Confirmed Schimke Immuno‐Osseous Dysplasia Who Developed Epstein–Barr Virus‐Positive Diffuse Large B‐Cell Lymphoma Eight Months Following Maternal Kidney Transplantation, Despite Reduced‐Intensity Immunosuppression. Rituximab Therapy Resulted in Complete Remission, but Required the Withdrawal of all Immunosuppressive Agents, Thereby Posing a Risk of Kidney Graft Loss. Result: In the Context of Primary Immunodeficiency and the Development of Post‐Transplant Lymphoproliferative Disorder in Such a Setting, the Patient Subsequently Underwent Haploidentical Hematopoietic Stem Cell Transplantation From the Mother, Using an αβ T‐Cell‐Depleted Graft and a Nephrotoxicity‐Sparing Conditioning Regimen. Full Donor Chimerism Was Achieved by Day 28. Immune Reconstitution Occurred Within One Year. At 27 Months After Hematopoietic Stem Cell Transplantation She Remains in Remission With Preserved Kidney Function and no Ongoing Immunosuppression. Conclusion: This Case Highlights the Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation as a Curative Salvage Strategy for Immunosuppression‐Free Survival After Kidney Transplantation in Patients With Schimke Immuno‐Osseous Dysplasia.
- Open Access
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (4) , 1322-1328
Hand-assisted laparoscopic donor nephrectomy: 1864 cases in 15 years of experience
Background/aim: To evaluate hand-assisted laparoscopic donor nephrectomy (HALDN) in terms of intraoperative and postoperative results. Materials and methods: After institutional review board approval was obtained, a total of 1864 HALDN operations performed between March 2007 and January 2022 were retrospectively analyzed. Age, sex, body mass index (BMI), status of smoking and presence of previous abdominal surgery, laterality, operative time, transfusion requirement, port counts, length of extraction incision, time until mobilization, time until oral intake, donor serum creatinine levels before and one week after the surgery, length of postoperative hospital stay, intraoperative complications, and postoperative recovery and complications were recorded and statistically analyzed. Multiple renal arteries, BMI, right nephrectomy and male sex were also separately evaluated as risk factors for complications and operative time. Results: A total of 825 (44.26%) male and 1039 (55.74%) female patients were enrolled in the study. The mean age of the patients was 45.79 ± 12.88 years. There were a total of 143 complications (7.67% of the total 1864 cases) consisting of 68 (3.65%) intraoperative and 75 (4.02%) postoperative complications. Open conversion was necessary for 10 patients (0.53%) to manage intraoperative complications. Reoperation was needed for 1 patient due to bleeding 6 h after the operation. Multiple renal arteries were a risk factor for intraoperative complications and prolonged operative time. Right nephrectomy and male sex were also related with longer operative times. Conclusions: HALDN is a safe procedure associated with low complication rates.
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (4) , 1322-1328
Open AccessHand-assisted laparoscopic donor nephrectomy: 1864 cases in 15 years of experience
Background/aim: To evaluate hand-assisted laparoscopic donor nephrectomy (HALDN) in terms of intraoperative and postoperative results. Materials and methods: After institutional review board approval was obtained, a total of 1864 HALDN operations performed between March 2007 and January 2022 were retrospectively analyzed. Age, sex, body mass index (BMI), status of smoking and presence of previous abdominal surgery, laterality, operative time, transfusion requirement, port counts, length of extraction incision, time until mobilization, time until oral intake, donor serum creatinine levels before and one week after the surgery, length of postoperative hospital stay, intraoperative complications, and postoperative recovery and complications were recorded and statistically analyzed. Multiple renal arteries, BMI, right nephrectomy and male sex were also separately evaluated as risk factors for complications and operative time. Results: A total of 825 (44.26%) male and 1039 (55.74%) female patients were enrolled in the study. The mean age of the patients was 45.79 ± 12.88 years. There were a total of 143 complications (7.67% of the total 1864 cases) consisting of 68 (3.65%) intraoperative and 75 (4.02%) postoperative complications. Open conversion was necessary for 10 patients (0.53%) to manage intraoperative complications. Reoperation was needed for 1 patient due to bleeding 6 h after the operation. Multiple renal arteries were a risk factor for intraoperative complications and prolonged operative time. Right nephrectomy and male sex were also related with longer operative times. Conclusions: HALDN is a safe procedure associated with low complication rates.
- 14 September 2021
- Published by Wiley in Pediatric Transplantation
- Vol. 25 (7) , e14142
Improving the urine spot protein/creatinine ratio by the estimated creatinine excretion to predict proteinuria in pediatric kidney transplant recipients
Background: Since the daily creatinine excretion rate (CER) is directly affected by muscle mass, which varies with age, gender, and body weight, using the spot protein/creatinine ratio (Spot P/Cr) follow‐up of proteinuria may not always be accurate. Estimated creatinine excretion rate (eCER) can be calculated from spot urine samples with formulas derived from anthropometric factors. Multiplying Spot P/Cr by eCER gives the estimated protein excretion rate (ePER). We aimed to determine the most applicable equation for predicting daily CER and examine whether ePER values acquired from different equations can anticipate measured 24 h urine protein (m24 h UP) better than Spot P/Cr in pediatric kidney transplant recipients.Methods: This study enrolled 23 children with kidney transplantation. To estimate m24 h UP, we calculated eCER and ePER values with three formulas adapted to children (Cockcroft‐Gault, Ghazali‐Barratt, and Hellerstein). To evaluate the accuracy of the methods, Passing‐Bablok and Bland‐Altman analysis were used.Results: A statistically significant correlation was found between m24 h UP and Spot P/Cr (p < .001, r = 0.850), and the correlation was enhanced by multiplying the Spot P/Cr by the eCER equations. The average bias of the ePER formulas adjusted by the Cockcroft‐Gault, Ghazali‐Barratt, and Hellerstein equations were −0.067, 0.031, and 0.064 g/day, respectively, whereas the average bias of Spot P/Cr was −0.270 g/day obtained by the Bland‐Altman graphics.Conclusion: Using equations to estimate eCER may improve the accuracy and reduce the spot urine samples’ bias in pediatric kidney transplantation recipients. Further studies in larger populations are needed for ePER reporting to be ready for clinical practice.
- 14 September 2021
- Published by Wiley in Pediatric Transplantation
- Vol. 25 (7) , e14142
Improving the urine spot protein/creatinine ratio by the estimated creatinine excretion to predict proteinuria in pediatric kidney transplant recipients
Background: Since the daily creatinine excretion rate (CER) is directly affected by muscle mass, which varies with age, gender, and body weight, using the spot protein/creatinine ratio (Spot P/Cr) follow‐up of proteinuria may not always be accurate. Estimated creatinine excretion rate (eCER) can be calculated from spot urine samples with formulas derived from anthropometric factors. Multiplying Spot P/Cr by eCER gives the estimated protein excretion rate (ePER). We aimed to determine the most applicable equation for predicting daily CER and examine whether ePER values acquired from different equations can anticipate measured 24 h urine protein (m24 h UP) better than Spot P/Cr in pediatric kidney transplant recipients.Methods: This study enrolled 23 children with kidney transplantation. To estimate m24 h UP, we calculated eCER and ePER values with three formulas adapted to children (Cockcroft‐Gault, Ghazali‐Barratt, and Hellerstein). To evaluate the accuracy of the methods, Passing‐Bablok and Bland‐Altman analysis were used.Results: A statistically significant correlation was found between m24 h UP and Spot P/Cr (p < .001, r = 0.850), and the correlation was enhanced by multiplying the Spot P/Cr by the eCER equations. The average bias of the ePER formulas adjusted by the Cockcroft‐Gault, Ghazali‐Barratt, and Hellerstein equations were −0.067, 0.031, and 0.064 g/day, respectively, whereas the average bias of Spot P/Cr was −0.270 g/day obtained by the Bland‐Altman graphics.Conclusion: Using equations to estimate eCER may improve the accuracy and reduce the spot urine samples’ bias in pediatric kidney transplantation recipients. Further studies in larger populations are needed for ePER reporting to be ready for clinical practice.
- 1 June 2016
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 39 (6) , 277-281
The Role of Midkine in the Inflammatory Process and Its Correlation with Other Inflammatory Markers in Renal Transplant Recipients
Background: Midkine (MK), which is expressed in the proximal tubular epithelial cells of the kidney, is thought to have a role in the pathophysiology of inflammation-related renal diseases. Both immunological and nonimmunological mechanisms may affect renal functions negatively during the early and late post-transplantation periods. We aimed in our study to evaluate the relationship of MK with clinical findings and inflammatory markers, including high sensitivity C-reactive protein (hs-CRP), interleukin (IL-6) and tumor necrosis factor (TNF-α) in the pretransplant and post-transplant period. Methods: Forty-one consecutive patients transplanted from living related donors were included in this prospective observational study. All patients received the same immunosuppressive treatment protocol. MK, hsCRP, IL-6 and TNF-α levels were measured before and 2 months after renal transplantation. Results: Pretransplant MK levels correlated positively with hsCRP (r = 0.41, p = 0.004) and IL-6 (r = 0.58, p<0.001). The mean post-transplant MK level was found to be higher than the pretransplant level (143 ± 350 pg/mL, 2792 ± 4235 pg/mL respectively, p = <0.001), while the mean hsCRP, IL-6 and TNF-α levels did not change significantly. Post-transplant IL-6 correlated significantly with MK (r = 0.388, p = 0.012), hsCRP (r = 0.41, p = 0.007) and TNF-α (r = 0.348, p = 0.026). There was no significant correlation between clinical findings and inflammatory markers. Conclusions: MK may be a good inflammatory marker in renal transplant recipients as in other inflammatory diseases. Moreover, it seems that it is not affected by factors other than inflammation during the post-transplantation period.
- 1 June 2016
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 39 (6) , 277-281
The Role of Midkine in the Inflammatory Process and Its Correlation with Other Inflammatory Markers in Renal Transplant Recipients
Background: Midkine (MK), which is expressed in the proximal tubular epithelial cells of the kidney, is thought to have a role in the pathophysiology of inflammation-related renal diseases. Both immunological and nonimmunological mechanisms may affect renal functions negatively during the early and late post-transplantation periods. We aimed in our study to evaluate the relationship of MK with clinical findings and inflammatory markers, including high sensitivity C-reactive protein (hs-CRP), interleukin (IL-6) and tumor necrosis factor (TNF-α) in the pretransplant and post-transplant period. Methods: Forty-one consecutive patients transplanted from living related donors were included in this prospective observational study. All patients received the same immunosuppressive treatment protocol. MK, hsCRP, IL-6 and TNF-α levels were measured before and 2 months after renal transplantation. Results: Pretransplant MK levels correlated positively with hsCRP (r = 0.41, p = 0.004) and IL-6 (r = 0.58, p<0.001). The mean post-transplant MK level was found to be higher than the pretransplant level (143 ± 350 pg/mL, 2792 ± 4235 pg/mL respectively, p = <0.001), while the mean hsCRP, IL-6 and TNF-α levels did not change significantly. Post-transplant IL-6 correlated significantly with MK (r = 0.388, p = 0.012), hsCRP (r = 0.41, p = 0.007) and TNF-α (r = 0.348, p = 0.026). There was no significant correlation between clinical findings and inflammatory markers. Conclusions: MK may be a good inflammatory marker in renal transplant recipients as in other inflammatory diseases. Moreover, it seems that it is not affected by factors other than inflammation during the post-transplantation period.
- 1 February 2010
- Published by SAGE Publications in Journal of Endourology
- Vol. 24 (2) , 247-251
Ureteral Complications in the Era of Laparoscopic Living Donor Nephrectomy: Do We Need to Preserve the Gonadal Vein with the Specimen?
Background and Purpose: The aim of this study was to analyze the ureteral complication rate in recipients transplanted with laparoscopically retrieved kidneys in our institution's 8-year experience when the gonal vein was not preserved with the specimen during the donor procedure. Patients and Methods: We reviewed the records of 800 consecutive laparoscopic donor nephrectomy patients. Donor sex, age, body mass index, warm ischemia time, hospital length of stay, donor and recipient serum creatinine levels, and incidence and type of complications including the incidence of ureteral complications were recorded. Results: Mean patient age was 39 ± 10 years. Mean body mass index was 27 ± 5. A total of 482 cases were treated purely laparoscopically. Of them, 318 were performed hand assisted. Seven hundred and ninety-three procedures were done on the left side and seven were done on the right side. The overall rate of intraoperative complications was 2.9%. The overall open conversion rate was 1.4%. The overall rate of postoperative complications was 3.9%. The postoperative day-7 serum creatinine values of the donors were 1.4 ± 0.3 mg/dL. Mean creatinine in all patients at 1 week after transplantation was 1.5 ± 0.2 mg/dL. We had one case of ureteral stricture in the recipients of laparoscopically procured kidneys without gonadal vein preservation technique among 800 patients. Conclusion: Gonadal vein preservation with the entire specimen during laparoscopic donor nephrectomy procedure is not a necessary step to protect periureteral blood supply to prevent ureteral strictures.
- 1 February 2010
- Published by SAGE Publications in Journal of Endourology
- Vol. 24 (2) , 247-251
Ureteral Complications in the Era of Laparoscopic Living Donor Nephrectomy: Do We Need to Preserve the Gonadal Vein with the Specimen?
Background and Purpose: The aim of this study was to analyze the ureteral complication rate in recipients transplanted with laparoscopically retrieved kidneys in our institution's 8-year experience when the gonal vein was not preserved with the specimen during the donor procedure. Patients and Methods: We reviewed the records of 800 consecutive laparoscopic donor nephrectomy patients. Donor sex, age, body mass index, warm ischemia time, hospital length of stay, donor and recipient serum creatinine levels, and incidence and type of complications including the incidence of ureteral complications were recorded. Results: Mean patient age was 39 ± 10 years. Mean body mass index was 27 ± 5. A total of 482 cases were treated purely laparoscopically. Of them, 318 were performed hand assisted. Seven hundred and ninety-three procedures were done on the left side and seven were done on the right side. The overall rate of intraoperative complications was 2.9%. The overall open conversion rate was 1.4%. The overall rate of postoperative complications was 3.9%. The postoperative day-7 serum creatinine values of the donors were 1.4 ± 0.3 mg/dL. Mean creatinine in all patients at 1 week after transplantation was 1.5 ± 0.2 mg/dL. We had one case of ureteral stricture in the recipients of laparoscopically procured kidneys without gonadal vein preservation technique among 800 patients. Conclusion: Gonadal vein preservation with the entire specimen during laparoscopic donor nephrectomy procedure is not a necessary step to protect periureteral blood supply to prevent ureteral strictures.
- 1 June 2009
- Published by Elsevier in Transplantation Proceedings
- Vol. 41 (5) , 1961-1962
Is Localized Prostate Cancer an Obstacle for an Immediate Consideration for Renal Transplantation? A Case Report
- 1 June 2009
- Published by Elsevier in Transplantation Proceedings
- Vol. 41 (5) , 1961-1962
Is Localized Prostate Cancer an Obstacle for an Immediate Consideration for Renal Transplantation? A Case Report
- 13 March 2009
- Published by Springer Nature in International Urology and Nephrology
- Vol. 41 (4) , 791-794
CD44 expression in renal ischemia-reperfusion injury in rats
Renal ischemia-reperfusion injury (IRI) is an invariable consequence of transplantation. The tubuloepithelial expression of CD44 is markedly enhanced in autoimmune renal injuries. The aim of this experimental study was to evaluate the effect of IRI on the expression of CD44 in rat kidney. Thirty male Sprague-Dawley rats were used. The rats were divided into three groups. The rats in group 1 (n = 10) underwent laparotomy and left nephrectomy (Sham surgery). The rats in group 2 (n = 10) underwent laparotomy, 1 h renal ischemia, followed by 1 h of reperfusion and then left nephrectomy was performed. The rats in group 3 (n = 10) underwent laparotomy, 1 h renal ischemia, followed by 24 h of reperfusion and then left nephrectomy was performed. Histopathological findings and the immunohistochemical expression of CD44 in ischemic and reperfused rat kidneys were investigated. In histopathologic evaluation, non-specific changes were observed in group 2 and early phase of IRI were present in group 3. CD44 was expressed in both group 2 and 3 but not in group 1. The mean immunohistochemical staining percentages of rat kidneys in group 1, 2, and 3 were 0.00 ± 0.00, 39.90 ± 5.53, and 26.20 ± 8.38, respectively. The immunohistochemical staining pattern was more dense in group 2 than in group 3 (P < 0.001). In conclusion, the expression of CD44 in renal tubuloepithelial cells was significantly increased after IRI. The increase in CD44 expression was more prominent during the early phase of IRI and started to decline after 24 h of reperfusion.
- 13 March 2009
- Published by Springer Nature in International Urology and Nephrology
- Vol. 41 (4) , 791-794
CD44 expression in renal ischemia-reperfusion injury in rats
Renal ischemia-reperfusion injury (IRI) is an invariable consequence of transplantation. The tubuloepithelial expression of CD44 is markedly enhanced in autoimmune renal injuries. The aim of this experimental study was to evaluate the effect of IRI on the expression of CD44 in rat kidney. Thirty male Sprague-Dawley rats were used. The rats were divided into three groups. The rats in group 1 (n = 10) underwent laparotomy and left nephrectomy (Sham surgery). The rats in group 2 (n = 10) underwent laparotomy, 1 h renal ischemia, followed by 1 h of reperfusion and then left nephrectomy was performed. The rats in group 3 (n = 10) underwent laparotomy, 1 h renal ischemia, followed by 24 h of reperfusion and then left nephrectomy was performed. Histopathological findings and the immunohistochemical expression of CD44 in ischemic and reperfused rat kidneys were investigated. In histopathologic evaluation, non-specific changes were observed in group 2 and early phase of IRI were present in group 3. CD44 was expressed in both group 2 and 3 but not in group 1. The mean immunohistochemical staining percentages of rat kidneys in group 1, 2, and 3 were 0.00 ± 0.00, 39.90 ± 5.53, and 26.20 ± 8.38, respectively. The immunohistochemical staining pattern was more dense in group 2 than in group 3 (P < 0.001). In conclusion, the expression of CD44 in renal tubuloepithelial cells was significantly increased after IRI. The increase in CD44 expression was more prominent during the early phase of IRI and started to decline after 24 h of reperfusion.